Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Iressa
Asia
Sanofi, AZ, Lilly and more win in China's expanded purchase bid
Altogether, seven foreign pharmas won bids in the expanded government drug purchase scheme versus only two in the original "4+7" pilot.
Angus Liu
Sep 25, 2019 11:02am
As AZ's cancer drugs surge, CEO talks up 'next phase'
Apr 26, 2019 10:25am
Big pharma loses out in China's latest procurement program
Dec 6, 2018 12:29pm
Pfizer's once-failed Vizimpro rebounds with FDA lung cancer nod
Sep 28, 2018 10:35am
Boehringer's Gilotrif widens its reach in EGFR lung cancer
Jan 17, 2018 10:17am
FiercePharmaAsia—Chi-Med, WuXi AppTec, Sun Pharma
Oct 20, 2017 10:53am
